Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights. 2017

Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
Department of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Semeling, 08100, Bedong, Kedah Darul Aman, Malaysia. venkateskumar@aimst.edu.my.

The dissolution and subsequent oral bioavailability of acyclovir (ACY) is limited by its poor aqueous solubility. An attempt has been made in this work to provide mechanistic insights into the solubility enhancement and dissolution of ACY by using the water-soluble carrier polyethylene glycol 6000 (PEG6000). Solid dispersions with varying ratios of the drug (ACY) and carrier (PEG6000) were prepared and evaluated by phase solubility, in vitro release studies, kinetic analysis, in situ perfusion, and in vitro permeation studies. Solid state characterization was done by powder X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) analysis, and surface morphology was assessed by polarizing microscopic image analysis, scanning electron microscopy, atomic force microscopy, and nuclear magnetic resonance analysis. Thermodynamic parameters indicated the solubilization effect of the carrier. The aqueous solubility and dissolution of ACY was found to be higher in all samples. The findings of XRD, DSC, FTIR and NMR analysis confirmed the formation of solid solution, crystallinity reduction, and the absence of interaction between the drug and carrier. SEM and AFM analysis reports ratified the particle size reduction and change in the surface morphology in samples. The permeation coefficient and amount of ACY diffused were higher in samples in comparison to pure ACY. Stability was found to be higher in dispersions. The results suggest that the study findings provided clear mechanical insights into the solubility and dissolution enhancement of ACY in PEG6000, and such findings could lay the platform for resolving the poor aqueous solubility issues in formulation development.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008855 Microscopy, Electron, Scanning Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY. Scanning Electron Microscopy,Electron Scanning Microscopy,Electron Microscopies, Scanning,Electron Microscopy, Scanning,Electron Scanning Microscopies,Microscopies, Electron Scanning,Microscopies, Scanning Electron,Microscopy, Electron Scanning,Microscopy, Scanning Electron,Scanning Electron Microscopies,Scanning Microscopies, Electron,Scanning Microscopy, Electron
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002152 Calorimetry, Differential Scanning Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Differential Thermal Analysis, Calorimetric,Calorimetric Differential Thermal Analysis,Differential Scanning Calorimetry,Scanning Calorimetry, Differential
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
December 1979, The Journal of pharmacy and pharmacology,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
August 2008, Drug delivery,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
January 1978, Pharmaceutica acta Helvetiae,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
January 2008, AAPS PharmSciTech,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
January 1980, Pharmaceutica acta Helvetiae,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
October 2011, Drug development and industrial pharmacy,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
December 2002, International journal of pharmaceutics,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
March 2004, International journal of pharmaceutics,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
July 1985, The Journal of pharmacy and pharmacology,
Krishnamoorthy Venkateskumar, and Subramani Parasuraman, and Raju Gunasunderi, and Krishnan Sureshkumar, and M Muralidhar Nayak, and Syed Adnan Ali Shah, and Khassen Khoo, and Heng Wei Kai
August 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!